Latest Lead News

AdNeo Limited’s recent acquisition, Aspire by Catapult, has won a significant $148,000 contract to develop Australia’s inaugural Advanced Diploma in Digital Innovation, marking a strategic expansion in the vocational education sector.

Heavy Rare Earths Limited has confirmed significant polymetallic mineralisation at its Prospect Hill Project in South Australia, revealing high-grade silver, copper, zinc, and lead alongside tin. The company plans a maiden drilling program to upgrade South Ridge to a JORC-compliant Mineral Resource Estimate.

Ballymore Resources has reported outstanding first assay results from its maiden drilling at the Torpy’s prospect, revealing exceptional grades of silver, lead, zinc, and critical indium. These findings highlight the prospect’s potential as a significant polymetallic discovery within the Ruddygore Project.

Core Energy Minerals has raised $2.75 million through a share placement to fund critical minerals exploration and the acquisition of the Itambe Rare Earth Project in Brazil, backed by strong institutional support.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Harmoney has secured a $15 million revolving debt facility from a major Australian bank, refinancing its previous loan at a significantly lower margin and underpinning future growth.

Regis Healthcare has agreed to sell two aged care homes in Far North Queensland to Ozcare, securing a $25 million pre-tax gain and signaling a strategic portfolio shift towards premium locations.

AdAlta Limited has received a $0.78 million Research and Development Tax Incentive refund for FY2025, using part of it to repay a Radium Capital loan and strengthening its cash position as it nears a key licensing milestone.

Argenica Therapeutics has demonstrated that its lead drug candidate ARG-007 does not interfere with the clot-busting agent tenecteplase, fulfilling a critical FDA requirement and advancing its stroke therapy development.

Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.

QPM Energy Limited has announced a $30 million equity raise to support the development of its Isaac Power Station, advancing toward a final investment decision in March 2026 and commissioning by mid-2027. The funding package, complemented by a $113.7 million lease agreement and a $40 million convertible note, underpins a project poised to strengthen Queensland’s energy transition.

QPM Energy Limited has had its trading suspension lifted following the announcement of a strategic investment term sheet and a capital raising, signaling renewed momentum for the energy company.